Evidence map›Paper›PMID 36744589›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2023

Absolute Configuration Determination of Chiral API Molecules by MicroED Analysis of Cocrystal Powders Formed Based on Cocrystal Propensity Prediction Calculations.

Harsh S Shah, Jiuchuang Yuan, Tian Xie, Zhuocen Yang, Chao Chang, Chandler Greenwell, Qun Zeng, GuangXu Sun, Brandon N Read, Timothy S Wilson and 5 more

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Harsh S ShahJ-STAR Research Inc., 6 Cedar Brook Dr, Cranbury, NJ 08512, USA.ORCID http://orcid.org/0000-0002-0678-5617
Jiuchuang YuanXtalPi Inc., Shenzhen Jingtai Technology Co., Ltd International Biomedical Innovation Park II 3F, No. 2 Hongliu Road, Futian District, Shenzhen, 518100, China.ORCID http://orcid.org/0000-0001-5462-719X
Tian XieJ-STAR Research Inc., 6 Cedar Brook Dr, Cranbury, NJ 08512, USA.
Zhuocen YangXtalPi Inc., Shenzhen Jingtai Technology Co., Ltd International Biomedical Innovation Park II 3F, No. 2 Hongliu Road, Futian District, Shenzhen, 518100, China.
Chao ChangXtalPi Inc., Shenzhen Jingtai Technology Co., Ltd International Biomedical Innovation Park II 3F, No. 2 Hongliu Road, Futian District, Shenzhen, 518100, China.
Chandler GreenwellXtalPi Inc., 245 Main St, 11th Floor, Cambridge, MA 02142, USA.ORCID http://orcid.org/0000-0002-5877-6296
Qun ZengXtalPi Inc., Shenzhen Jingtai Technology Co., Ltd International Biomedical Innovation Park II 3F, No. 2 Hongliu Road, Futian District, Shenzhen, 518100, China.
GuangXu SunXtalPi Inc., Shenzhen Jingtai Technology Co., Ltd International Biomedical Innovation Park II 3F, No. 2 Hongliu Road, Futian District, Shenzhen, 518100, China.
Brandon N ReadNanoImaging Services Inc., 4940 Carroll Canyon Road, Suite 115, San Diego, CA 92121, USA.
Timothy S WilsonNanoImaging Services Inc., 4940 Carroll Canyon Road, Suite 115, San Diego, CA 92121, USA.
Henry U ValleNanoImaging Services Inc., 4940 Carroll Canyon Road, Suite 115, San Diego, CA 92121, USA.ORCID http://orcid.org/0000-0001-7540-4083
Shanming KuangJ-STAR Research Inc., 6 Cedar Brook Dr, Cranbury, NJ 08512, USA.
Jian WangJ-STAR Research Inc., 6 Cedar Brook Dr, Cranbury, NJ 08512, USA.
Sivakumar SekharanXtalPi Inc., 245 Main St, 11th Floor, Cambridge, MA 02142, USA.ORCID http://orcid.org/0000-0003-4747-2139
Jessica F BruhnNanoImaging Services Inc., 4940 Carroll Canyon Road, Suite 115, San Diego, CA 92121, USA.ORCID http://orcid.org/0000-0002-3356-5994

Funding

A microED pipeline for the pharmaceutical and biotechnology industryR44GM140666 · NIGMS · NANOIMAGING SERVICES, INC. · PI BRUHN, JESSICA FOX, SCAPIN, GIOVANNA · 2021 to 2022
$1.4M
National Institute of Health - NIH 1R44GM140666NIGMS NIH HHS R44 GM140666
6 · The paper itself

Abstract

Establishing the absolute configuration of chiral active pharmaceutical ingredients (APIs) is of great importance. Single crystal X-ray diffraction (scXRD) has traditionally been the method of choice for such analysis, but scXRD requires the growth of large crystals, which can be challenging. Here, we present a method for determining absolute configuration that does not rely on the growth of large crystals. By examining microcrystals formed with chiral probes (small chiral compounds such as amino acids), absolute configuration can be unambiguously determined by microcrystal electron diffraction (MicroED). Our streamlined method employs three steps: (1) virtual screening to identify promising chiral probes, (2) experimental cocrystal screening and (3) structure determination by MicroED and absolute configuration assignment. We successfully applied this method to analyze two chiral API molecules currently on the market for which scXRD was not used to determine absolute configuration.

Indexed as

absolute configurationcrystal engineeringelectron diffractionMicroEDvirtual screening

Identifiers

PMID36744589
PMCPMC10089073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.